tiprankstipranks
Trending News
More News >

Amneal Pharmaceuticals sees FY25 adjusted EPS 65c-75c, consensus 71c

Sees FY25 revenue $3B-$3.1B, consensus $2.92B. Sees FY25 adjusted EBITDA $650M-$675M.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1